Hyperfine Market Cap Over Time
| HYPR Stock | USD 1.02 0.04 4.08% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Hyperfine Performance and Hyperfine Correlation. Hyperfine |
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Hyperfine. If investors know Hyperfine will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Hyperfine listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.57) | Revenue Per Share 0.166 | Quarterly Revenue Growth 0.074 | Return On Assets (0.30) | Return On Equity (0.49) |
The market value of Hyperfine is measured differently than its book value, which is the value of Hyperfine that is recorded on the company's balance sheet. Investors also form their own opinion of Hyperfine's value that differs from its market value or its book value, called intrinsic value, which is Hyperfine's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Hyperfine's market value can be influenced by many factors that don't directly affect Hyperfine's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Hyperfine's value and its price as these two are different measures arrived at by different means. Investors typically determine if Hyperfine is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Hyperfine's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Market Cap Analysis
Compare Hyperfine and related stocks such as ProSomnus, Common Stock, Neuropace, and Orthopediatrics Corp Market Cap Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NPCE | 594.8 M | 594.8 M | 594.8 M | 594.8 M | 594.8 M | 594.8 M | 594.8 M | 594.8 M | 594.8 M | 594.8 M | 594.8 M | 246.5 M | 36.6 M | 266.5 M | 382.6 M |
| KIDS | 143 M | 143 M | 143 M | 143 M | 143 M | 144.4 M | 144.4 M | 92.4 M | 438.4 M | 687.2 M | 1.2 B | 1.2 B | 822.6 M | 737.2 M | 387.8 M |
| ANIK | 9.8 M | 128 M | 131.8 M | 537.6 M | 598 M | 643.7 M | 643.7 M | 643.7 M | 643.7 M | 643.7 M | 643.7 M | 643.7 M | 643.7 M | 579.3 M | 608.3 M |
| PAVM | 89.5 M | 89.5 M | 89.5 M | 89.5 M | 89.5 M | 89.5 M | 89.5 M | 30.8 M | 21.4 M | 100.6 M | 100.6 M | 42.8 M | 42.8 M | 29.8 M | 57.7 M |
| LIVN | 1.5 B | 1.9 B | 1.9 B | 1.9 B | 1.9 B | 4.4 B | 4.4 B | 4.4 B | 4.4 B | 3.6 B | 3.2 B | 3.2 B | 3.2 B | 2.9 B | 3 B |
| ELMD | 21.6 M | 17 M | 10.6 M | 11.4 M | 15 M | 31.4 M | 45.2 M | 44.5 M | 43.9 M | 129.3 M | 96.7 M | 81.7 M | 90.6 M | 121.2 M | 127.2 M |
| SRDX | 47.8 M | 961.9 M | 961.9 M | 961.9 M | 961.9 M | 961.9 M | 961.9 M | 961.9 M | 527.3 M | 527.3 M | 450.3 M | 450.3 M | 450.3 M | 405.2 M | 422.9 M |
| LUNG | 814.1 M | 814.1 M | 814.1 M | 814.1 M | 814.1 M | 814.1 M | 814.1 M | 814.1 M | 814.1 M | 1.4 B | 2.5 B | 1.2 B | 312.7 M | 484.2 M | 460 M |
| IRMD | 112.8 M | 112.8 M | 112.8 M | 112.8 M | 112.8 M | 308.4 M | 120.1 M | 161.2 M | 296.2 M | 263.8 M | 276.4 M | 570.5 M | 355.4 M | 598.3 M | 628.2 M |
| OFIX | 96.2 M | 641.9 M | 746.4 M | 426.7 M | 554.9 M | 737 M | 656.5 M | 991 M | 970.8 M | 873 M | 828.1 M | 612.2 M | 411.7 M | 495.1 M | 426.2 M |
| ITGR | 127.7 M | 1.1 B | 1.1 B | 1.1 B | 478.8 M | 478.8 M | 478.8 M | 478.8 M | 478.8 M | 478.8 M | 478.8 M | 478.8 M | 478.8 M | 431 M | 462.4 M |
| INGN | 219.9 M | 219.9 M | 219.9 M | 273.4 M | 507.6 M | 777.7 M | 1.3 B | 2.5 B | 2.8 B | 1.5 B | 982.1 M | 450.4 M | 450.4 M | 127.2 M | 120.9 M |
| APYX | 28.2 M | 114.4 M | 114.4 M | 114.4 M | 114.4 M | 114.4 M | 114.4 M | 114.4 M | 114.4 M | 114.4 M | 114.4 M | 114.4 M | 114.4 M | 103 M | 66.7 M |
Hyperfine and related stocks such as ProSomnus, Common Stock, Neuropace, and Orthopediatrics Corp Market Cap description
My Equities
My Current Equities and Potential Positions
| Hyperfine | HYPR |
Specialization | Health Care, Health Care Equipment & Services |
| Location | Connecticut; U.S.A |
| Exchange | NASDAQ Exchange |
USD 1.02
Additional Tools for Hyperfine Stock Analysis
When running Hyperfine's price analysis, check to measure Hyperfine's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hyperfine is operating at the current time. Most of Hyperfine's value examination focuses on studying past and present price action to predict the probability of Hyperfine's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hyperfine's price. Additionally, you may evaluate how the addition of Hyperfine to your portfolios can decrease your overall portfolio volatility.